These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11363130)

  • 1. Dapsone not affected by chewable ddI.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection.
    Mirochnick M; Cooper E; Capparelli E; McIntosh K; Lindsey J; Xu J; Jacobus D; Mofenson L; Bonagura VR; Nachman S; Yogev R; Sullivan JL; Spector SA
    Clin Pharmacol Ther; 2001 Jul; 70(1):24-32. PubMed ID: 11452241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to PCP medications found to be low.
    TreatmentUpdate; 1998 Sep; 10(7):2-3. PubMed ID: 11365780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia.
    Horowitz HW; Wormser GP
    N Engl J Med; 1999 May; 340(19):1512-3. PubMed ID: 10328722
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternative dapsone dosage regimen for prophylaxis of Pneumocystis carinii pneumonia.
    Gatti G; Fioredda F; Lorusso C; Cruciani M; Bassetti D
    Pediatr Infect Dis J; 1996 Feb; 15(2):183-4. PubMed ID: 8822303
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis.
    Carlin EM; Coker RJ; Goldin RD; Harris JR
    Genitourin Med; 1993 Apr; 69(2):130-2. PubMed ID: 8509094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of pneumonia related to HIV--pneumocystis carinii pneumonia (PCP)].
    Sidahora; 1995; ():31-2. PubMed ID: 11363204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of trimetrexate and dapsone in AIDS patients with Pneumocystis carinii pneumonia.
    Koda RT; Dubé MP; Li WY; Chatterjee DJ; Stansell JD; Sattler FR
    J Clin Pharmacol; 1999 Mar; 39(3):268-74. PubMed ID: 10073326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone for prevention of Pneumocystis pneumonia in children with acquired immunodeficiency syndrome.
    Barnett ED; Pelton SI; Mirochnick M; Cooper ER
    Pediatr Infect Dis J; 1994 Jan; 13(1):72-4. PubMed ID: 8170736
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group.
    McIntosh K; Cooper E; Xu J; Mirochnick M; Lindsey J; Jacobus D; Mofenson L; Yogev R; Spector SA; Sullivan JL; Sacks H; Kovacs A; Nachman S; Sleasman J; Bonagura V; McNamara J
    Pediatr Infect Dis J; 1999 May; 18(5):432-9. PubMed ID: 10353516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protect yourself from Pneumocystis carinii.
    AIDS Alert; 1999 Jun; 14(6):suppl 1-2. PubMed ID: 11366414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions in use of dapsone for Pneumocystis carinii prophylaxis.
    Horowitz HW; Jorde UP; Wormser GP
    Lancet; 1992 Mar; 339(8795):747. PubMed ID: 1347616
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of dapsone prophylaxis against Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children.
    Stavola JJ; Noel GJ
    Pediatr Infect Dis J; 1993 Aug; 12(8):644-7. PubMed ID: 8414776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dapsone in the prevention of HIV-related parasitosis].
    Garavelli PL
    Recenti Prog Med; 1996 Jun; 87(6):279. PubMed ID: 8766954
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
    Podzamczer D; Martos A; Ferrer I; Santin M; Gudiol F
    Clin Infect Dis; 1993 Jan; 16(1):171. PubMed ID: 8448298
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure of prophylaxis with dapsone in patients taking dideoxyinosine.
    Metroka CE; McMechan MF; Andrada R; Laubenstein LJ; Jacobus DP
    N Engl J Med; 1991 Sep; 325(10):737. PubMed ID: 1908060
    [No Abstract]   [Full Text] [Related]  

  • 17. Penetration of dapsone into lung of human immunodeficiency virus-infected children.
    Gatti G; Loy A; Lorusso C; Rossi G; Bassetti D
    Pediatr Infect Dis J; 1997 May; 16(5):523-4. PubMed ID: 9154550
    [No Abstract]   [Full Text] [Related]  

  • 18. Does dapsone increase mortality when given for prophylaxis of Pneumocystis carinii pneumonia?
    Opravil M; Hirschel B; Lüthy R
    AIDS; 1996 Aug; 10(9):1045-6. PubMed ID: 8853742
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing PCP therapy.
    Torres G; Cadman J
    GMHC Treat Issues; 1997 Oct; 11(10):3-5. PubMed ID: 11364821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone in low doses prevents Pneumocystis carinii pneumonia in the rat model.
    González-Ruiz A; Haworth SJ; O'Neil AB; Warhurst DC
    J Infect; 1991 Mar; 22(2):143-52. PubMed ID: 2026888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.